From April 8 to 12, the 2025 Wuzhen Health Conference and the 4th China OTC Conference were grandly held. During the event, several authoritative industry awards were presented. Pudilan Xiaoyan Oral Liquid was honored with the "West Lake Award · the Most Popular Star Product in Pharmacies" in recognition of its excellent product quality and widespread market acceptance, highlighting its value in both retail and medical fields.

 

 

The conference featured multiple professional and distinctive forums focusing on pharmaceutical innovation, digital transformation, traditional Chinese medicine development, and cross-industry innovation. It brought together tens of thousands of experts, academicians, business leaders, and industry elites in the health sector. As one of the most influential awards in China's pharmaceutical retail industry, the "the Most Popular Star Product in Pharmacies” aims to recognize products with market impact, channel support, and sustainable development potential. The award sets a benchmark for value in pharmaceutical retail, promotes the building of Chinese pharmaceutical brands, enhances their social image and influence, and drives the optimization and upgrading of the pharmaceutical industry. This honor is a high endorsement of Pudilan Xiaoyan Oral Liquid's brand building, product quality, and reputation.

 

Pudilan Xiaoyan Oral Liquid is an exclusive formulation product. Using modern pharmaceutical processes, imported production equipment, and patented extraction technology, it is meticulously produced by JumpCan Pharmaceutical through multiple steps including pretreatment, extraction, ingredient mixing, filling, sterilization, light inspection, packaging, and storage. Dandelion, Isatis root, and Viola yedoensis are processed through water extraction and alcohol precipitation, while Scutellaria baicalensis undergoes extraction and purification to remove impurities and retain essential components. This results in an oral liquid formulation that offers enhanced efficacy and greater convenience.

 

According to Menet data, Pudilan Xiaoyan Oral Liquid has consistently ranked among the top brands in the heat-clearing and detoxifying traditional Chinese medicine segment in China's urban retail pharmacies for many years, earning widespread praise from pharmacies and consumers. In March of this year, it was also awarded the "2024–2025 Best-Selling Brand in China's Pharmaceutical Retail Market". In 2024, Pudilan successfully expanded its status from prescription to dual-status drug (both Rx and OTC), allowing consumers to purchase it directly at pharmacies without a prescription, further improving medication convenience and accessibility.

 

 

This recognition is rooted in product quality and the trust of doctors, pharmacists, and consumers. Over the years, JumpCan Pharmaceutical has always anchored its efforts in patient needs, deepening its expertise in key areas such as pediatrics, respiratory, and digestive health. The company combines tradition with innovation, ensures strict control over the entire production process to guarantee stable and reliable drug quality, and integrates modern pharmaceutical technology to build a diverse product matrix. In the future, JumpCan will continue to pragmatically enhance drug quality standards, safeguard public health with refined craftsmanship, develop more patient-benefiting branded products, and write a more solid chapter in the healthcare sector.